Status:
NOT_YET_RECRUITING
A Quick and Reliable Eye Movement Test to Help Diagnose ADHD in Children.
Lead Sponsor:
Onovis Augenpraxis
Conditions:
Attention Deficit Disorder With Hyperactivity (ADHD)
Attention Deficit Disorder (ADD)
Eligibility:
All Genders
8-16 years
Brief Summary
Attention Deficit Hyperactivity Disorder (ADHD) affects more than 5 % of children and adolescents, with a globally increasing prevalence. The condition imposes a significant burden on affected individ...
Detailed Description
Attention Deficit Hyperactivity Disorder (ADHD) is one of the most common neurodevelopmental disorders in children and adolescents. It is estimated that over 5 % of young people worldwide are affected...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- For the ADHD group:
- Clinically confirmed diagnosis of ADHD by an expert (e.g., pediatrician, neuropsychologist, pediatric neurologist)
- Age between 8 and 16 years
- Written informed consent from the participant and/or legal guardian
- For the control group (non-ADHD):
- Age between 8 and 16 years
- No suspicion of ADHD
- Written informed consent from the participant and/or legal guardian
- Exclusion Criteria:
- For both groups:
- Medical conditions known to affect ocular motor behavior (e.g., neurological or ophthalmological disorders)
- Doubts regarding the accuracy of the ADHD diagnosis (for the ADHD group)
- Lack of or questionable informed consent
- Suspicion of ADHD in control group participants (reported by parents, examiner, or physician)
Exclusion
Key Trial Info
Start Date :
September 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 31 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT07136259
Start Date
September 1 2025
End Date
January 31 2026
Last Update
August 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
OnovisAugenpraxis
Bern, Canton of Bern, Switzerland, 3011